Vitrosys Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.3M

  • Investors
  • 3

Vitrosys General Information

Description

Developer of a biotechnology company intended to create a complete plant-based medicine from a single cell or a single tissue. The company manufactures and sells a variety of quality wild ginseng cultured root products in strictly controlled facilities, extracts, separates, analyzes, and identifies natural metabolites that have useful physiological activity for the human body, enabling people to consume natural drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17, Jukryeong- ro 1371beon-gil, Punggi-eup
  • Yeongju, Gyeongsangbuk
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 17, Jukryeong- ro 1371beon-gil, Punggi-eup
  • Yeongju, Gyeongsangbuk
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vitrosys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Aug-2022 $2.3M Completed Generating Revenue
1. Seed Round 01-Jan-2014 Completed Generating Revenue
To view Vitrosys’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vitrosys Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kwang Dong Pharmaceutical Corporation Minority
Lifecore Partners Venture Capital Minority
Solidus Investment Venture Capital Minority
To view Vitrosys’s complete investors history, request access »

Vitrosys FAQs

  • When was Vitrosys founded?

    Vitrosys was founded in 2002.

  • Where is Vitrosys headquartered?

    Vitrosys is headquartered in Yeongju, South Korea.

  • What industry is Vitrosys in?

    Vitrosys’s primary industry is Drug Discovery.

  • Is Vitrosys a private or public company?

    Vitrosys is a Private company.

  • What is Vitrosys’s current revenue?

    The current revenue for Vitrosys is .

  • How much funding has Vitrosys raised over time?

    Vitrosys has raised $2.3M.

  • Who are Vitrosys’s investors?

    Kwang Dong Pharmaceutical, Lifecore Partners, and Solidus Investment have invested in Vitrosys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process